How does the intensity of therapy to lower HbA1c affect long-term cardiovascular risk in patients with type 2 diabetes mellitus?
Metadata[+] Show full item record
Intensive glycemic control (glycosylated hemoglobin [HbA1c] <6%) is associated with significantly lower rates of nonfatal myocardial infarction (MI) and coronary heart disease (CHD) compared with standard glycemic control; however, there does not appear to be a benefit on all-cause mortality (SOR: A, meta-analysis of RCTs).
Evidence-based practice 16, no. 02 (2013): 08